THOMAS JEFFERSON UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1824-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.jefferson.edu
A Research Study Examining the Use of Olanzapine for the Prevention of Migraine
Not Applicable
Terminated
- Conditions
- Migraine
- Interventions
- Drug: Placebo during first intervention period, then olanzapine during second intervention period
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2011-08-25
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 3
- Registration Number
- NCT00203307
- Locations
- 🇺🇸
Jefferson Headache Center, Philadelphia, Pennsylvania, United States
A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches
Not Applicable
Completed
- Conditions
- Migraine
- Interventions
- Procedure: Transcranial Magnetic Stimulation
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2011-08-11
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 31
- Registration Number
- NCT00203216
- Locations
- 🇺🇸
Jefferson Headache Center, Philadelphia, Pennsylvania, United States
Research Study Examining Nerve Block for Migraine
Completed
- Conditions
- Migraine
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2009-01-23
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 30
- Registration Number
- NCT00203346
- Locations
- 🇺🇸
Jefferson Headache Center, Philadelphia, Pennsylvania, United States
Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache
Not Applicable
Completed
- Conditions
- Migraine Headache
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2009-01-23
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 25
- Registration Number
- NCT00203255
- Locations
- 🇺🇸
Jefferson Headache Center, Philadelphia, Pennsylvania, United States
A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache
Phase 4
Terminated
- Conditions
- Cluster Headache
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2009-01-23
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 60
- Registration Number
- NCT00203190
- Locations
- 🇺🇸
Jefferson Headache Center, Philadelphia, Pennsylvania, United States
An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER for the Treatment of Cluster Headaches.
Not Applicable
Completed
- Conditions
- Cluster Headache
- Interventions
- Drug: Depacon IV and Depakote ER
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2011-07-15
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 15
- Registration Number
- NCT00203242
- Locations
- 🇺🇸
Jefferson Headache Center, Philadelphia, Pennsylvania, United States
Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-06-03
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 20
- Registration Number
- NCT00203229
- Locations
- 🇺🇸
Jefferson Headache Center, Philadelphia, Pennsylvania, United States
Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
Completed
- Conditions
- Refractory EpilepsyArrhythmiaSudden Death
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2016-10-18
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 19
- Registration Number
- NCT00203333
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Preventing Depression in Patients With Macular Degeneration
Phase 3
Completed
- Conditions
- DepressionMacular Degeneration
- Interventions
- Behavioral: Problem Solving TreatmentBehavioral: Control
- First Posted Date
- 2002-07-26
- Last Posted Date
- 2014-01-08
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 206
- Registration Number
- NCT00042211
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
GM1 Ganglioside Effects on Parkinson's Disease
- First Posted Date
- 2002-05-23
- Last Posted Date
- 2012-12-21
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 94
- Registration Number
- NCT00037830
- Locations
- 🇺🇸
Parkinson's Disease Research Unit, Thomas Jefferson University, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath